Monsenso
Market Cap
kr.158.3m
Last Updated
2021/01/26 18:03 UTC
Data Sources
Company Financials
Executive Summary
Monsenso A/S develops and sells cloud-based solutions for the treatment of individuals with a mental disorder. More Details
Risk Analysis
Snowflake Analysis
Excellent balance sheet with weak fundamentals.
Share Price & News
How has Monsenso's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MONSO is more volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: MONSO's weekly volatility has decreased from 24% to 10% over the past year, but is still higher than 75% of Danish stocks.
Market Performance
7 Day Return
-0.8%
MONSO
1.0%
DK Healthcare Services
1.3%
DK Market
1 Year Return
n/a
MONSO
28.5%
DK Healthcare Services
26.9%
DK Market
Return vs Industry: Insufficient data to determine how MONSO performed against the Danish Healthcare Services industry.
Return vs Market: Insufficient data to determine how MONSO performed against the Danish Market.
Shareholder returns
| MONSO | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.8% | 1.0% | 1.3% |
| 30 Day | -1.2% | 5.3% | 3.2% |
| 90 Day | 22.7% | 16.3% | 13.1% |
| 1 Year | n/a | 29.6%28.5% | 29.3%26.9% |
| 3 Year | n/a | 34.1%29.7% | 56.1%43.9% |
| 5 Year | n/a | 92.7%80.8% | 68.0%46.4% |
Long-Term Price Volatility Vs. Market
How volatile is Monsenso's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 months ago | Simply Wall St
Should Monsenso A/S (CPH:MONSO) Focus On Improving This Fundamental Metric?Valuation
Is Monsenso undervalued compared to its fair value and its price relative to the market?
8x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: MONSO (DKK11.98) is trading above our estimate of fair value (DKK7.88)
Significantly Below Fair Value: MONSO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MONSO is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.
PE vs Market: MONSO is unprofitable, so we can't compare its PE Ratio to the Danish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MONSO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MONSO is overvalued based on its PB Ratio (8x) compared to the XE Healthcare Services industry average (5x).
Next Steps
Future Growth
How is Monsenso forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
22.4%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Monsenso has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine Monsenso's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Monsenso competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Monsenso performed over the past 5 years?
22.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MONSO is currently unprofitable.
Growing Profit Margin: MONSO is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: MONSO is unprofitable, but has reduced losses over the past 5 years at a rate of 22.8% per year.
Accelerating Growth: Unable to compare MONSO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MONSO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-10.6%).
Return on Equity
High ROE: MONSO has a negative Return on Equity (-13.65%), as it is currently unprofitable.
Next Steps
Financial Health
How is Monsenso's financial position?
Financial Position Analysis
Short Term Liabilities: MONSO's short term assets (DKK21.3M) exceed its short term liabilities (DKK1.6M).
Long Term Liabilities: MONSO's short term assets (DKK21.3M) exceed its long term liabilities (DKK8.0M).
Debt to Equity History and Analysis
Debt Level: MONSO's debt to equity ratio (17.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if MONSO's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable MONSO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: MONSO is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 196.4% per year.
Next Steps
Dividend
What is Monsenso current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MONSO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MONSO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MONSO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MONSO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MONSO's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.4yrs
Average management tenure
CEO
Thomas Lethenborg (51 yo)
5.92yrs
Tenure
Mr. Thomas Lethenborg has been Chief Executive Officer, President Manager and Member of the Executive Board at Monsenso A/S since February 2, 2015. Mr. Lethenborg was Regional Director of Nordics & Baltics...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President Manager & Member of the Executive Board | 5.92yrs | no data | no data | |
| Co-Founder & Deputy Chairman of the Board | 2.58yrs | no data | no data | |
| Co-Founder & DPO | no data | no data | no data | |
| Chief Financial Officer | 0.42yr | no data | no data | |
| Chief Operating Operations | 0.42yr | no data | no data | |
| Chief Technology Officer | 0.25yr | no data | no data | |
| Chief Marketing Officer | 0.42yr | no data | no data | |
| Chief Product Officer | 0.083yr | no data | no data |
0.4yrs
Average Tenure
Experienced Management: MONSO's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Deputy Chairman of the Board | 2.58yrs | no data | no data | |
| Director | 6.67yrs | no data | no data | |
| Director | 2.58yrs | no data | no data | |
| Chairman of the Board | 2.58yrs | no data | no data |
2.6yrs
Average Tenure
55yo
Average Age
Experienced Board: MONSO's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: MONSO only recently listed within the past 12 months.
Top Shareholders
Company Information
Monsenso A/S's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Monsenso A/S
- Ticker: MONSO
- Exchange: CPSE
- Founded: 2013
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: kr.158.321m
- Shares outstanding: 13.22m
- Website: https://www.monsenso.com
Number of Employees
Location
- Monsenso A/S
- Ny Carlsbergvej 80
- Copenhagen V
- Copenhagen
- Capital Region of Denmark
- 1799
- Denmark
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MONSO | CPSE (OMX Nordic Exchange Copenhagen) | Yes | Share Capital | DK | DKK | Jun 2020 |
Biography
Monsenso A/S develops and sells cloud-based solutions for the treatment of individuals with a mental disorder. It offers Smartphone app for individuals help them in the areas of self-assessments, sensor da...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/26 18:03 |
| End of Day Share Price | 2021/01/26 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.